These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 26669820)
1. Assessment of the efficacy of drug transdermal delivery by electro-phonophoresis in treating tuberculous lymphadenitis. Chen S; Qin M; Han Y; Zhao L; Fu Y; Shang Y; Liu Z; Huang H Drug Deliv; 2016 Jun; 23(5):1588-93. PubMed ID: 26669820 [TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of isoniazid and rifampin in guinea pigs by electro-phonophoresis. Chen S; Han Y; Yu D; Huo F; Wang F; Li Y; Dong L; Liu Z; Huang H Drug Deliv; 2017 Nov; 24(1):467-470. PubMed ID: 28181840 [TBL] [Abstract][Full Text] [Related]
3. Drug transdermal delivery by electrophonophoresis can increase the concentration of rifampicin in the pleural effusion of patients with tuberculous pleurisy but has no effect on the concentration of rifampicin in plasma. Liu Q; Chen L; He JQ Int Immunopharmacol; 2023 Apr; 117():109892. PubMed ID: 37012884 [TBL] [Abstract][Full Text] [Related]
4. Effects of repeated administration of rifampicin and isoniazid on vitamin D metabolism in mice. Sheng L; Xue Y; He X; Zhu Y; Li H; Wu Y; Dang R; Tang M; Jiang P Steroids; 2015 Dec; 104():203-7. PubMed ID: 26476181 [TBL] [Abstract][Full Text] [Related]
5. Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles. Kumarasingam K; Vincent M; Mane SR; Shunmugam R; Sivakumar S; Uma Devi KR Int J Mycobacteriol; 2018; 7(1):84-88. PubMed ID: 29516891 [TBL] [Abstract][Full Text] [Related]
6. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery. Xu W; Wei X; Wei K; Cao X; Zhong S Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077 [TBL] [Abstract][Full Text] [Related]
7. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system]. Isakova ZhT Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033 [TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124 [TBL] [Abstract][Full Text] [Related]
9. Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid. Moretton MA; Hocht C; Taira C; Sosnik A Nanomedicine (Lond); 2014 Aug; 9(11):1635-50. PubMed ID: 24410279 [TBL] [Abstract][Full Text] [Related]
10. Mycolic acid index susceptibility method for Mycobacterium tuberculosis. Viader-Salvadó JM; Garza-González E; Valdez-Leal R; del Bosque-Moncayo MA; Tijerina-Menchaca R; Guerrero-Olazarán M J Clin Microbiol; 2001 Jul; 39(7):2642-5. PubMed ID: 11427584 [TBL] [Abstract][Full Text] [Related]
11. [Measurement of rifampicin concentrations in tuberculous pleural effusion before and after combination treatment with oral and local rifampicin]. Liu QX; Guo DT; Chen L; Ou SP; Huang L; Yan H; Zheng XC; Weng CX; Zhang JY Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):853-856. PubMed ID: 30423627 [No Abstract] [Full Text] [Related]
12. Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea. Cho EH; Bae HK; Kang SK; Lee EH Korean J Lab Med; 2009 Oct; 29(5):455-60. PubMed ID: 19893355 [TBL] [Abstract][Full Text] [Related]
13. Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: phenotypic and genotypic methods. Miyata M; Pavan FR; Sato DN; Marino LB; Hirata MH; Cardoso RF; de Melo FA; Zanelli CF; Leite CQ Biomed Pharmacother; 2011 Sep; 65(6):456-9. PubMed ID: 21880463 [TBL] [Abstract][Full Text] [Related]
14. Ascorbic acid improves stability and pharmacokinetics of rifampicin in the presence of isoniazid. Rajaram S; Vemuri VD; Natham R J Pharm Biomed Anal; 2014 Nov; 100():103-108. PubMed ID: 25151231 [TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar. Coban AY; Bilgin K; Uzun M; Tasdelen Fisgin N; Akgunes A; Cihan CC; Birinci A; Durupinar B J Clin Microbiol; 2005 Apr; 43(4):1930-1. PubMed ID: 15815022 [TBL] [Abstract][Full Text] [Related]
16. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis. Long MW; Snider DE; Farer LS Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the GenoType MTBDR assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. Saglik I; Oz Y; Kiraz N Indian J Med Microbiol; 2014; 32(3):318-22. PubMed ID: 25008829 [TBL] [Abstract][Full Text] [Related]
18. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. Brossier F; Veziris N; Truffot-Pernot C; Jarlier V; Sougakoff W J Clin Microbiol; 2006 Oct; 44(10):3659-64. PubMed ID: 17021094 [TBL] [Abstract][Full Text] [Related]
19. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity. Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163 [TBL] [Abstract][Full Text] [Related]
20. Drug-resistant tuberculosis in Budapest. Fodor T; Vadász I; Lõrinczi I Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]